Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- What are the effects of pharmacological interventions to prevent atrial fibrillation after heart surgery?
- How does amiodarone compare with placebo for the prevention of sudden cardiac death in at-risk adults?
- What are the effects of non-pharmacological interventions to prevent atrial fibrillation after heart surgery?
- How do factor Xa inhibitors compare with warfarin for prevention of cerebral and systemic embolism in people with atrial fibrillation (AF)?
- How do antiarrhythmic drugs compare for maintaining sinus rhythm after cardioversion of atrial fibrillation (AF)?
- What are the benefits and harms of antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation (AF)?
- What are the effects of ablation for people with non-paroxysmal atrial fibrillation?
Use of this content is subject to our disclaimer